Chronic Kidney Disease (CKD): Progressive loss of kidney function over months or years, characterized by decreased glomerular filtration rate (GFR) and/or evidence of kidney damage, such as proteinuria or structural abnormalities, persisting for more than 3 months.
Insufficient Renal Function (IR): Reduced kidney ability to filter waste and maintain fluid-electrolyte balance, often indicated by elevated serum creatinine and decreased GFR.
Prevalence & Risk Factors: High prevalence linked to diabetes (over 61%), obesity, sedentary lifestyle, and hypertension; significant contributor to cardiovascular morbidity.
Complications: Include cardiovascular disease, anemia, mineral and bone disorders, and foot ulcers; CKD increases risk of end-stage renal disease (ESRD).
Epidemiology: Increasing global burden; in Argentina, CKD prevalence is notable, with a high rate of associated comorbidities like diabetes and hypertension.
Progression & Staging: CKD stages are based on GFR (Stage 1: normal/high GFR with damage, Stage 5: ESRD requiring dialysis or transplant). Early detection is crucial for slowing progression.
Chronic Kidney Disease is a progressive, multifactorial condition that significantly impacts overall health, especially cardiovascular risk; early detection and management of risk factors are essential to slow its progression and prevent complications.
Dissection of the Aorta: A tear in the aortic intima causing blood to split the layers of the vessel wall, presenting with sudden chest pain radiating to the back and a murmur of mitral insufficiency.
Arrhythmias: Abnormal heart rhythms, including atrial fibrillation (AF), ventricular tachycardia (VT), and Wolff-Parkinson-White (WPW) syndrome, which can lead to sudden cardiac death.
Heart Failure (HF): A condition where the heart's ability to pump blood is impaired, classified by ejection fraction (EF): reduced (<40%) or preserved (>50%).
Cor Pulmonale: Right ventricular hypertrophy and failure due to pulmonary hypertension, often secondary to left-sided heart disease or lung pathology.
Myocarditis: Inflammation of the myocardium, frequently viral, which can cause arrhythmias, heart failure, or sudden death.
Pericarditis: Inflammation of the pericardium, often viral, characterized by chest pain, pericardial rub, and specific ECG changes.
Epidemiology: Diabetes and obesity are major risk factors for cardiovascular complications; Argentina's prevalence of diabetes is 12.7%, with 25% at risk for foot ulcers.
Clinical Manifestations: Dissection presents with acute chest/back pain; heart failure symptoms include dyspnea, edema, and fatigue; arrhythmias may be asymptomatic or cause palpitations.
Diagnostic Tools: ECG for arrhythmias; echocardiography for ventricular function; cardiac MRI for myocarditis and mass assessment; catheterization for pulmonary hypertension.
Management Principles:
Special Conditions:
Cardiovascular complications encompass a wide spectrum, from arrhythmias to heart failure and vascular dissections, requiring prompt diagnosis and tailored management to prevent mortality and improve quality of life.
Heart Failure (HF): A clinical syndrome where the heart's ability to pump blood is insufficient to meet the body's metabolic needs, leading to symptoms like dyspnea, fatigue, and fluid retention.
Ejection Fraction (EF): The percentage of blood ejected from the left ventricle during systole; used to classify HF into:
NYHA Functional Classification: A system to assess HF severity based on symptoms and physical activity:
Neurohormonal Activation: Pathophysiological process involving activation of systems like the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system, contributing to HF progression.
Decompensation: An acute worsening of HF symptoms requiring intensified treatment, often hospitalization.
Diagnosis: Based on clinical symptoms (dyspnea, edema) and echocardiography to assess EF. Biomarkers like BNP or NT-proBNP aid in diagnosis and prognosis.
Treatment Goals: Improve symptoms, reduce hospitalizations, and prolong survival by modulating neurohormonal pathways and managing comorbidities.
Pharmacologic Therapy:
Non-Pharmacologic Interventions: Device therapy (ICD, CRT), lifestyle modifications (salt restriction, fluid management), and in advanced cases, heart transplantation.
Monitoring & Follow-up: Regular assessment of symptoms, EF, renal function, electrolytes, and adherence to therapy.
Acute Management: Oxygen therapy, diuretics for volume overload, vasodilators, inotropes in cardiogenic shock, and mechanical ventilation if needed.
Effective heart failure management combines pharmacologic treatment, lifestyle modifications, and device therapy tailored to HF type and severity, aiming to improve quality of life and survival. Early detection and prompt intervention are crucial to prevent decompensation and progression.
Valvular Heart Disease (VHD): Disorders involving malfunction of one or more heart valves, leading to stenosis (narrowing) or regurgitation (leakage).
Stenosis: Narrowing of a heart valve that impedes blood flow, causing increased pressure upstream and reduced cardiac output.
Regurgitation (Insufficiency): Incomplete closure of a valve, resulting in backward blood flow during systole or diastole, leading to volume overload.
Aortic Valve Disease: Usually involves calcific stenosis in elderly or congenital bicuspid valves, leading to obstructed outflow.
Mitral Valve Disease: Commonly involves mitral stenosis (often rheumatic) or regurgitation, causing volume overload of the left atrium and ventricle.
Echocardiography: Primary diagnostic tool for assessing valve morphology, function, and severity of stenosis/regurgitation.
Etiology: Rheumatic fever is the most common cause of mitral stenosis; degenerative calcific changes predominate in aortic stenosis in the elderly; congenital bicuspid aortic valves predispose to early stenosis.
Clinical Manifestations:
Physical Exam Findings:
Complications: Heart failure, atrial fibrillation, thromboembolism, infective endocarditis, and pulmonary hypertension.
Management:
Valvular heart diseases primarily cause either obstructive or regurgitant flow, leading to volume or pressure overload; early diagnosis via echocardiography and timely intervention are crucial to prevent heart failure and other complications.
Arrhythmia: An abnormal heart rhythm resulting from irregular electrical activity in the myocardium, which can cause too fast (tachycardia), too slow (bradycardia), or irregular heartbeats.
Atrial Fibrillation (AF): A common supraventricular arrhythmia characterized by chaotic, rapid electrical impulses in the atria, leading to ineffective atrial contractions and irregular ventricular response.
Ventricular Tachycardia (VT): A rapid heart rhythm originating from the ventricles, often sustained and potentially life-threatening, which can degenerate into ventricular fibrillation.
Sinus Node Dysfunction: Impairment of the sinoatrial node's ability to generate impulses properly, leading to sinus bradycardia or sinus arrest.
Reentry: A mechanism of arrhythmia where an electrical impulse continuously cycles within a circuit, causing rapid and repetitive activation of myocardium.
Electrocardiogram (ECG): A diagnostic tool that records the electrical activity of the heart, essential for identifying and classifying arrhythmias.
Pathophysiology: Arrhythmias often result from disturbances in impulse formation (automaticity), conduction pathways, or reentry circuits, frequently associated with structural heart disease such as ischemia, cardiomyopathies, or fibrosis.
Clinical Significance: Arrhythmias can cause symptoms like palpitations, dizziness, syncope, or sudden cardiac death. Their management depends on the type, severity, and underlying heart disease.
Diagnosis: ECG is the primary diagnostic modality. Holter monitoring, event recorders, and electrophysiological studies are used for persistent or complex arrhythmias.
Treatment Strategies:
Arrhythmia and Heart Disease Relationship: Structural abnormalities like myocardial infarction, heart failure, or hypertrophy predispose to arrhythmias; arrhythmias can exacerbate heart failure or precipitate ischemia.
Arrhythmias are common in heart disease, arising from electrical disturbances often linked to structural cardiac abnormalities, and require precise diagnosis and tailored treatment to prevent adverse outcomes such as stroke or sudden cardiac death.
Cor pulmonale results from pulmonary hypertension due to lung pathology, leading to right ventricular hypertrophy and failure; early detection and management of underlying causes are essential to prevent progression.
Pulmonary Hypertension (PH): Elevated pressure in the pulmonary arteries, defined hemodynamically as mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg at rest, leading to increased workload on the right ventricle.
Pre-capillary PH: Elevated pulmonary artery pressure due to issues in the pulmonary arteries themselves, characterized by normal pulmonary capillary wedge pressure (PCWP ≤ 15 mmHg).
Post-capillary PH: Elevated pulmonary pressure secondary to left heart disease, with increased PCWP (> 15 mmHg), reflecting elevated left atrial pressure.
Pulmonary Vascular Resistance (PVR): Resistance that the right ventricle must overcome to pump blood through the pulmonary circulation; increased in PH, calculated as (mean PAP - PCWP) / cardiac output.
Cor Pulmonale: Right heart failure resulting from pulmonary hypertension, characterized by right ventricular hypertrophy and dilation.
WHO Classification of PH: Categorizes PH into five groups based on etiology:
Etiology: PH can be idiopathic, heritable, drug-induced, or secondary to conditions like left heart failure, lung diseases, chronic thromboembolism, or connective tissue diseases.
Pathophysiology: Chronic elevation of pulmonary arterial pressure causes vascular remodeling, vasoconstriction, and increased PVR, which strain the right ventricle leading to hypertrophy and eventual failure.
Clinical Presentation: Symptoms include exertional dyspnea, fatigue, chest pain, syncope, and signs of right heart failure such as peripheral edema, hepatomegaly, and jugular venous distension.
Diagnosis: Confirmed via right heart catheterization (gold standard). Echocardiography estimates pulmonary pressures and assesses right ventricular function. Other tests include chest imaging, pulmonary function tests, and V/Q scan.
Treatment: Targets underlying causes, uses vasodilators (e.g., prostacyclins, endothelin receptor antagonists, phosphodiesterase-5 inhibitors), oxygen therapy, diuretics, and anticoagulation in specific cases. Advanced cases may require lung transplantation.
Pulmonary hypertension is a complex, multifactorial condition characterized by increased pulmonary arterial pressure that leads to right heart failure; early diagnosis and targeted therapy are essential to improve outcomes.
Myocarditis: Inflammation of the myocardium (heart muscle), often caused by infections, immune responses, or toxins, leading to myocardial injury and potential heart failure or arrhythmias.
Dilated Cardiomyopathy (DCM): A condition characterized by dilation and impaired contraction of the ventricles, resulting in systolic heart failure; often idiopathic but can be secondary to myocarditis, toxins, or genetic factors.
Hypertrophic Cardiomyopathy (HCM): A genetic disorder involving abnormal thickening of the myocardium, especially the interventricular septum, leading to diastolic dysfunction and risk of sudden cardiac death.
Restrictive Cardiomyopathy: A rare form where the myocardium becomes rigid, impairing ventricular filling while systolic function remains preserved; causes include infiltrative diseases like amyloidosis.
Viral Myocarditis: The most common etiology of myocarditis, frequently caused by viruses such as Coxsackie B, Adenovirus, or Parvovirus B19, leading to direct myocardial injury.
Myocardial Injury Markers: Elevated troponin levels indicating myocardial damage; used in diagnosis of myocarditis and other cardiac injuries.
Etiology: Myocarditis is often viral but can also result from bacterial infections, autoimmune diseases, toxins, or drugs.
Pathophysiology: Inflammatory response causes myocardial cell necrosis, fibrosis, and potential remodeling, which can progress to dilated cardiomyopathy.
Clinical Presentation:
Diagnosis:
Treatment:
Cardiomyopathies:
Myocarditis is an inflammatory myocardial condition that can lead to dilated cardiomyopathy and heart failure; early recognition and management are crucial to prevent irreversible cardiac damage. Cardiomyopathies, whether dilated, hypertrophic, or restrictive, are structural heart diseases with distinct pathophysiology, clinical features, and management strategies.
Infectious Endocarditis (IE): An infection of the endocardial surface of the heart, typically involving heart valves, caused by bacteria, fungi, or other microorganisms.
Vegetations: Clusters of microorganisms, fibrin, and inflammatory cells attached to the heart valves or endocardium, characteristic of IE.
Risk Factors: Conditions increasing IE risk, including prosthetic valves, previous endocarditis, congenital heart defects, intravenous drug use, and immunosuppression.
Microorganisms: Common causative agents include Streptococcus viridans, Staphylococcus aureus, HACEK group bacteria, and fungi, with the pathogen influencing treatment choice.
Diagnosis Criteria (Duke Criteria): A combination of clinical, microbiological, and echocardiographic findings used to confirm IE, categorized as major and minor criteria.
Complications: Embolic events, heart failure due to valvular destruction, abscess formation, and systemic embolization of vegetations.
Pathogenesis: Bacteria adhere to damaged endocardium or prosthetic material, forming vegetations that can embolize or cause tissue destruction.
Clinical Presentation: Fever, new or changing heart murmurs, embolic phenomena (e.g., stroke, petechiae), and signs of heart failure.
Diagnosis: Blood cultures (at least 2 sets), echocardiography (preferably transesophageal), and application of Duke criteria to establish definitive or probable IE.
Treatment: Prolonged intravenous antibiotics tailored to the causative organism; surgical intervention may be necessary for heart failure, persistent infection, or large vegetations.
Prevention: Antibiotic prophylaxis before certain procedures in high-risk patients, especially with prosthetic valves or prior IE.
Infectious endocarditis is a serious, potentially life-threatening infection characterized by vegetations on heart valves, requiring prompt diagnosis and targeted antimicrobial therapy to prevent severe complications.
Congenital Heart Defect (CHD): Structural abnormality of the heart present at birth, resulting from improper development during fetal life.
Ventricular Septal Defect (VSD): An opening in the interventricular septum allowing blood flow between the left and right ventricles.
Atrial Septal Defect (ASD): An opening in the interatrial septum, causing left-to-right shunt of blood.
Patent Ductus Arteriosus (PDA): Persistence of the ductus arteriosus after birth, leading to abnormal blood flow between the aorta and pulmonary artery.
Tetralogy of Fallot (TOF): A combination of four heart anomalies: VSD, pulmonary stenosis, right ventricular hypertrophy, and overriding aorta.
Cyanotic vs. Acyanotic Defects: Cyanotic defects cause right-to-left shunting leading to hypoxemia; acyanotic defects involve left-to-right shunts without cyanosis.
Classification: Congenital heart defects are categorized as cyanotic or acyanotic based on blood oxygenation and shunt direction.
Pathophysiology: Abnormal connections or obstructions alter normal blood flow, leading to symptoms like cyanosis, heart failure, or murmurs.
Diagnosis: Key clinical signs include murmurs, cyanosis, and growth delays. Confirmed via echocardiography, chest X-ray, and sometimes cardiac MRI.
Management: Ranges from observation in mild cases to surgical correction or catheter-based interventions in complex defects.
Associated Conditions: CHDs may be isolated or part of syndromes like Down syndrome, DiGeorge syndrome, or Noonan syndrome.
Prognosis: Depends on defect type, severity, and timing of intervention; early detection improves outcomes.
Congenital heart defects encompass a wide spectrum of structural abnormalities that can significantly impact a child's health; early diagnosis and appropriate intervention are crucial for optimal outcomes.
| Feature | Heart Failure with Reduced Ejection Fraction (HFrEF) | Heart Failure with Preserved Ejection Fraction (HFpEF) |
|---|---|---|
| Ejection Fraction (EF) | <40% | ≥50% |
| Pathophysiology | Systolic dysfunction | Diastolic dysfunction |
| Common causes | Ischemic heart disease, cardiomyopathies | Hypertension, aging, obesity |
| Treatment focus | Neurohormonal blockade (ACEi, beta-blockers) | Control of comorbidities, diuretics for symptoms |
| Response to therapy | Significant benefit from medications | Limited evidence for specific drugs |
| Valve Disease Type | Stenosis | Regurgitation |
|---|---|---|
| Definition | Narrowing impeding blood flow | Valve fails to close properly, causing backflow |
| Hemodynamic effect | Increased pressure proximal to valve | Volume overload of upstream chambers |
| Common sites | Aortic, mitral, pulmonary, tricuspid | Aortic, mitral, pulmonary, tricuspid |
| Typical causes | Calcification, rheumatic fever, congenital defects | Rheumatic disease, endocarditis, MVP |
| Clinical signs | Murmur with crescendo-decrescendo, syncope (stenosis) | Murmur with holosystolic or diastolic pattern |
Testez vos connaissances sur Comprehensive Cardiovascular and Renal Disease Overview avec 9 questions à choix multiples avec corrections détaillées.
1. What is Chronic Kidney Disease primarily characterized by?
2. What is the primary characteristic that distinguishes Chronic Kidney Disease (CKD) from Insufficient Renal Function (IR)?
Mémorisez les concepts clés de Comprehensive Cardiovascular and Renal Disease Overview avec 10 flashcards interactives.
Chronic Kidney Disease — definition?
Progressive loss of kidney function over months or years.
CKD — definition?
Progressive loss of kidney function over months or years.
Cardiovascular complications — key example?
Aortic dissection, arrhythmias, or heart failure.
Importe ton cours et l'IA génère fiches, QCM et flashcards en 30 secondes.
Générateur de fiches